Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma
Authors
Taylor, JTEllison, S
Pandele, A
Wood, S
Nathan, E
Forte, G
Parker, H
Zindy, E
Elvin, M
Dickson, A
Williams, KJ
Karabatsou, K
McCabe, Martin
McBain, Catherine A
Bigger, BW
Affiliation
Brain Tumor Research Group, Stem Cell and Neurotherapies Laboratory, Division of Cell Matrix Biology & Regenerative Medicine, University of Manchester, United Kingdom.Issue Date
2020
Metadata
Show full item recordCitation
Taylor JT, Ellison S, Pandele A, Wood S, Nathan E, Forte G, et al. Actinomycin D Downregulates Sox2 and Improves Survival in Preclinical Models of Recurrent Glioblastoma. Neuro Oncol. 2020.Journal
Neuro-OncologyDOI
10.1093/neuonc/noaa051PubMed ID
32227096Additional Links
https://dx.doi.org/10.1093/neuonc/noaa051Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/neuonc/noaa051
Scopus Count
Collections
Related articles
- Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.
- Authors: Bijangi-Vishehsaraei K, Reza Saadatzadeh M, Wang H, Nguyen A, Kamocka MM, Cai W, Cohen-Gadol AA, Halum SL, Sarkaria JN, Pollok KE, Safa AR
- Issue date: 2017 Dec
- Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
- Authors: Clark PA, Bhattacharya S, Elmayan A, Darjatmoko SR, Thuro BA, Yan MB, van Ginkel PR, Polans AS, Kuo JS
- Issue date: 2017 May
- Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
- Authors: Iglesia RP, Prado MB, Cruz L, Martins VR, Santos TG, Lopes MH
- Issue date: 2017 Apr 17
- Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma.
- Authors: Qazi MA, Vora P, Venugopal C, Adams J, Singh M, Hu A, Gorelik M, Subapanditha MK, Savage N, Yang J, Chokshi C, London M, Gont A, Bobrowski D, Grinshtein N, Brown KR, Murty NK, Nilvebrant J, Kaplan D, Moffat J, Sidhu S, Singh SK
- Issue date: 2018 Sep 1
- Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
- Authors: Garner JM, Ellison DW, Finkelstein D, Ganguly D, Du Z, Sims M, Yang CH, Interiano RB, Davidoff AM, Pfeffer LM
- Issue date: 2015